Intractable & Rare Diseases Research

Scope & Guideline

Bridging Gaps in Rare Disease Knowledge.

Introduction

Welcome to your portal for understanding Intractable & Rare Diseases Research, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2186-3644
PublisherINT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT
Support Open AccessNo
CountryJapan
TypeJournal
Convergefrom 2012 to 2024
AbbreviationINTRACTABLE RARE DIS / INTRACTABLE RARE DIS. RES.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressINT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT, TOKYO 00000, JAPAN

Aims and Scopes

The journal 'Intractable & Rare Diseases Research' focuses on the complex landscape of rare and intractable diseases, providing a platform for innovative research that addresses both clinical and scientific challenges. Its aim is to enhance understanding, diagnosis, and treatment of these conditions through rigorous analysis and interdisciplinary collaboration.
  1. Epidemiology of Rare Diseases:
    The journal emphasizes the importance of understanding the prevalence and distribution of rare diseases, including comprehensive epidemiological studies that highlight the burden these conditions place on healthcare systems.
  2. Genetic and Molecular Research:
    Research on the genetic underpinnings of rare diseases is a core focus, including studies on genetic mutations, biomarkers, and the development of genetic diagnostics that facilitate better patient management.
  3. Clinical Management and Treatment Approaches:
    Papers often explore novel treatment strategies and management protocols for rare diseases, including case studies, clinical trials, and reviews that contribute to improved patient outcomes.
  4. Patient-Centered Research:
    The journal prioritizes research that includes patient perspectives, quality of life assessments, and psychosocial impacts of living with rare diseases, fostering a holistic understanding of these conditions.
  5. Innovative Technologies in Rare Disease Research:
    There is a consistent interest in the application of advanced technologies, such as artificial intelligence and metabolomics, to improve diagnostics, treatment efficacy, and understanding of disease mechanisms.
The journal has identified and embraced several emerging themes that reflect the evolving landscape of rare disease research. These trends highlight areas of growing importance and potential impact on clinical practice and patient care.
  1. Integration of Artificial Intelligence in Rare Disease Research:
    A significant trend is the increasing incorporation of artificial intelligence technologies in diagnosing and managing rare diseases, showcasing innovative methodologies that enhance precision medicine.
  2. Focus on Quality of Life and Patient Experiences:
    There is a growing emphasis on understanding the quality of life and psychological impacts of rare diseases, indicating a shift towards more holistic patient-centered research.
  3. Innovations in Genetic Diagnostics:
    Emerging themes include advances in genetic diagnostics, such as whole-exome sequencing and next-generation sequencing technologies, which are revolutionizing the understanding and management of genetic disorders.
  4. Interdisciplinary Collaborations:
    Research that involves interdisciplinary approaches, combining insights from genetics, epidemiology, and clinical practice, is increasingly prominent, reflecting the complex nature of rare diseases.
  5. Emerging Treatments and Therapeutics:
    There is a rising interest in novel therapeutic approaches, including gene therapies and personalized medicine strategies, that promise to address unmet needs in rare disease treatment.

Declining or Waning

While the journal has seen a rich variety of themes over the years, certain areas appear to be declining in prominence. This may reflect shifts in research focus or advancements in knowledge and technology that have rendered some topics less critical.
  1. General Reviews of Rare Diseases:
    There has been a noticeable decrease in broader reviews of rare diseases as more targeted, specific studies emerge. The focus is shifting towards in-depth analyses rather than general overviews.
  2. Historical Perspectives:
    Papers that provide historical context or retrospective analyses of rare diseases are appearing less frequently, suggesting a trend towards more forward-looking research that emphasizes current issues and future directions.
  3. Basic Science without Clinical Relevance:
    Research that delves into basic science aspects of rare diseases without a clear clinical application or relevance is becoming less common, as the journal increasingly favors studies that bridge the gap between laboratory findings and clinical practice.
  4. Epidemiological Studies in Developed Regions:
    There appears to be a waning interest in epidemiological studies focused solely on developed countries, likely as the journal aims to highlight the global burden of rare diseases, particularly in under-researched regions.

Similar Journals

Case Reports in Immunology

Empowering Researchers with Open-Access Immunology Reports
Publisher: HINDAWI LTDISSN: 2090-6609Frequency:

Case Reports in Immunology, published by HINDAWI LTD, is an esteemed open-access journal that has been contributing to the field of immunology since its launch in 2011. With both ISSN 2090-6609 and E-ISSN 2090-6617, the journal provides a platform for researchers to publish detailed case reports that explore diverse immunological conditions and novel treatment approaches. This journal is crucial for clinicians, researchers, and students alike, seeking to broaden their understanding of immunology's practical applications and advances. As of 2023, it holds a Q3 ranking in Immunology and Q2 in Immunology and Allergy, reflecting its growing relevance and contribution to the field. Additionally, it is indexed in Scopus, where it ranks #178 in Immunology and Allergy and #192 in Immunology and Microbiology, enhancing its visibility and impact. With a comprehensive accessibility model, the journal is dedicated to disseminating knowledge widely and enriching discussions in immunological research.

Case Reports in Oncological Medicine

Empowering healthcare professionals with valuable case reports.
Publisher: HINDAWI LTDISSN: 2090-6706Frequency: 1 issue/year

Case Reports in Oncological Medicine is a distinguished open-access journal published by HINDAWI LTD, dedicated to disseminating valuable insights and findings in the field of oncology. Since its inception in 2011, this journal has aimed to provide a unique platform for the publication of detailed case reports that contribute to our understanding of cancer diagnosis, treatment, and management. With a specific focus on sharing clinical experiences and outcomes, it seeks to engage researchers, healthcare professionals, and students who are committed to advancing oncological knowledge and improving patient care. Although coverage in Scopus was discontinued from 2014 to 2017, the journal currently holds a rank of #232/323 in Medicine - Oncology, placing it within the 28th percentile. Researchers interested in making their work accessible can benefit from the journal's open-access model, allowing greater visibility and citation potential within the scientific community. The journal is positioned as an important resource for those looking to stay updated on the latest case studies and innovations in oncological medicine.

Biomedical Reports

Advancing knowledge in the heart of biomedical sciences.
Publisher: SPANDIDOS PUBL LTDISSN: 2049-9434Frequency: 6 issues/year

Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.

Journal of Pediatric Infectious Diseases

Navigating the complexities of pediatric infections.
Publisher: GEORG THIEME VERLAG KGISSN: 1305-7707Frequency: 4 issues/year

Journal of Pediatric Infectious Diseases, published by GEORG THIEME VERLAG KG, serves as a vital platform for the dissemination of cutting-edge research in the fields of pediatric infectious diseases and related areas. With an ISSN of 1305-7707 and an E-ISSN of 1305-7693, this journal endeavors to address critical issues and innovations in pediatric medicine, fostering an understanding of infectious diseases that affect children. The journal is indexed in Scopus, where it holds a Q4 ranking in both Infectious Diseases and Pediatrics, Perinatology and Child Health, reflecting its emerging status within medical research. Although currently not open access, it offers valuable insights and empirical research crucial for healthcare professionals, researchers, and students dedicated to improving pediatric care. The Journal of Pediatric Infectious Diseases not only highlights contemporary challenges faced by pediatric health practitioners but also aims to be a cornerstone for future developments in the management and prevention of infections in young populations.

YONAGO ACTA MEDICA

Elevating Peer-Reviewed Medicine to New Heights
Publisher: TOTTORI UNIV MEDICAL PRESSISSN: 0513-5710Frequency: 4 issues/year

YONAGO ACTA MEDICA, published by Tottori University Medical Press, is a prominent journal in the field of Medicine, recognized for its contributions and academic rigor since its inception in 1965. With an ISSN of 0513-5710 and E-ISSN of 1346-8049, this journal is situated in Japan and spans significant periods of convergence from 1965 to 1977 and from 1986 to 2024. Classified within the Q3 category of Medicine (Miscellaneous) and holding a respectable Scopus rank of 275 out of 636 in General Medicine, YONAGO ACTA MEDICA offers an invaluable platform for researchers, professionals, and students to disseminate innovative studies and findings in diverse medical topics. While the journal currently does not operate under an open-access model, it remains committed to promoting academic excellence and advancing medical knowledge through peer-reviewed publications. Address inquiries and contributions to 86 NISHI-CHO, YONAGO, TOTTORI-KEN 683-8503, JAPAN.

International Journal of Clinical and Experimental Pathology

Advancing Knowledge in Pathology and Beyond
Publisher: E-CENTURY PUBLISHING CORPISSN: 1936-2625Frequency: 12 issues/year

International Journal of Clinical and Experimental Pathology, published by E-CENTURY PUBLISHING CORP, serves as a vital resource for professionals in the field of pathology. With its ISSN 1936-2625, the journal has positioned itself within the competitive landscape of medical journals, achieving commendable rankings in Scopus, particularly in the categories of Pathology and Forensic Medicine (Rank #98/185) and Histology (Rank #38/58). Although its coverage in Scopus has been discontinued, the journal’s past contributions from 2009 to 2017 continue to be a touchstone for researchers interested in advancing their understanding of clinical and experimental pathology. The open-access format ensures accessibility to a wide audience, fostering collaboration and education in this essential medical discipline. By bridging clinical research and experimental findings, this journal plays a crucial role in disseminating knowledge and enhancing practices within pathology, making it an indispensable tool for researchers, professionals, and students alike.

BMJ Case Reports

Documenting the Unseen: Case Reports that Matter
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 1 issue/year

BMJ Case Reports is a vital resource within the field of medicine, published by the esteemed BMJ PUBLISHING GROUP. With an E-ISSN of 1757-790X and a focus on disseminating high-quality case reports, this journal serves as a platform for healthcare professionals, researchers, and students to share unique clinical experiences and uncommon presentations of medical conditions. Since its inception in 2008 and continuing through 2024, it has gained recognition for contributing to the advancement of medical knowledge, currently ranking at Q4 in the Medicine (miscellaneous) category and positioned in the 54th percentile in General Medicine according to Scopus rankings. Although it is a subscription-based journal, its impact on clinical practice and education is significant, enabling practitioners to learn from diverse case studies and improving patient care outcomes. As it aims to enhance the understanding of rare and significant medical cases, BMJ Case Reports remains an essential publication for those at the forefront of medical innovation.

Case Reports in Medicine

Exploring the nuances of medicine through compelling case reports.
Publisher: HINDAWI LTDISSN: 1687-9627Frequency: 1 issue/year

Case Reports in Medicine is a distinguished journal published by HINDAWI LTD, focusing on the vital field of medical case studies and reports. Since its inception in 2009, this Open Access journal has offered a platform for sharing novel insights, challenges, and outcomes encountered in clinical practice. Located in the United States, it serves a global audience of researchers and healthcare professionals, emphasizing the importance of case reports in advancing medical knowledge and promoting evidence-based practice. With an impressive ranking of Q3 in Medicine (miscellaneous) and a solid performance at #265/636 in General Medicine (58th percentile) as per Scopus, the journal is recognized for its impactful contributions to the medical community. Through its commitment to disseminating quality research, Case Reports in Medicine plays a crucial role in fostering collaboration and enhancing patient care worldwide, making it an essential resource for students, researchers, and practitioners alike.

Nature Reviews Disease Primers

Transforming Insights into Clinical Impact
Publisher: NATURE PORTFOLIOISSN: 2056-676XFrequency: 1 issue/year

Nature Reviews Disease Primers, published by NATURE PORTFOLIO, stands as a leading journal in the field of Medicine, specifically recognized for its comprehensive coverage of various diseases and health-related topics. With an impressive impact factor that reflects its high citation rate, this journal is categorized within the Q1 quartile in Medicine (miscellaneous) and holds a prestigious Scopus rank of #4 out of 636, placing it in the 99th percentile of general medicine publications. Launched in 2015 and projected to continue its influence until 2024, the journal aims to bridge the gap between clinical research and practical application, providing easy-to-digest primers that summarize current understanding and emerging trends in various diseases. While not classified as open access, its rigorously peer-reviewed content remains crucial for academic researchers, healthcare professionals, and students alike, striving to stay at the forefront of medical knowledge. The journal's base in the United Kingdom enhances its global reach, contributing to the ongoing dialogue in the medical community.

Journal of Egyptian Womens Dermatological Society

Exploring the Intersection of Women's Health and Dermatology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1687-1537Frequency: 3 issues/year

The Journal of Egyptian Women's Dermatological Society, published by Wolters Kluwer Medknow Publications, is an essential platform dedicated to advancing the field of dermatology through a valuable focus on women's health issues. Established to provide an open access outlet since 2019, this journal aims to disseminate research, case studies, and reviews that address the unique dermatological needs and concerns of women, particularly in the Egyptian context. Despite its current ranking in the Q4 category in dermatology and a Scopus rank of #117 out of 142 with a 17th percentile, the journal serves a critical role in fostering scholarly communication among researchers, clinicians, and academicians. With a commitment to promoting knowledge advancement and community engagement, this journal invites submissions that align with its objectives, specifically geared towards empirical research and innovative practices in dermatology impacting women's health.